British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults

CA Lamb, NA Kennedy, T Raine, PA Hendy, PJ Smith… - Gut, 2019 - gut.bmj.com
Ulcerative colitis and Crohn's disease are the principal forms of inflammatory bowel disease.
Both represent chronic inflammation of the gastrointestinal tract, which displays …

A comprehensive review and update on ulcerative colitis

M Gajendran, P Loganathan, G Jimenez, AP Catinella… - Disease-a-month, 2019 - Elsevier
Ulcerative colitis (UC) is a chronic idiopathic inflammatory bowel disorder of the colon that
causes continuous mucosal inflammation extending from the rectum to the more proximal …

Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: definitions, diagnosis, extra-intestinal manifestations …

F Magro, P Gionchetti, R Eliakim… - Journal of Crohn's …, 2017 - academic.oup.com
1.2. Definitions Ulcerative colitis [UC] is a chronic inflammatory condition that causes
continuous mucosal inflammation of the colon, usually without granulomas on biopsy. It …

ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 2: IBD scores and general principles and technical aspects

A Sturm, C Maaser, E Calabrese… - Journal of Crohn's …, 2019 - academic.oup.com
There are several scoring systems presently available to classify disease severity in
ulcerative colitis [UC] within the multiple domains of disease activity, which aid objective …

Findings from a randomized controlled trial of fecal transplantation for patients with ulcerative colitis

NG Rossen, S Fuentes, MJ van der Spek, JG Tijssen… - Gastroenterology, 2015 - Elsevier
Background & Aims Several case series have reported the effects of fecal microbiota
transplantation (FMT) for ulcerative colitis (UC). We assessed the efficacy and safety of FMT …

[HTML][HTML] Defining disease severity in inflammatory bowel diseases: current and future directions

L Peyrin-Biroulet, J Panés, WJ Sandborn… - Clinical …, 2016 - Elsevier
Although most treatment algorithms in inflammatory bowel disease (IBD) begin with
classifying patients according to disease severity, no formal validated or consensus …

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis

A Dignass, R Eliakim, F Magro, C Maaser… - Journal of Crohn's …, 2012 - academic.oup.com
Ulcerative colitis is a lifelong disease arising from an interaction between genetic and
environmental factors, observed predominantly in the developed countries of the world. The …

Optimizing anti-TNF-α therapy: serum levels of infliximab and adalimumab are associated with mucosal healing in patients with inflammatory bowel diseases

B Ungar, I Levy, Y Yavne, M Yavzori, O Picard… - Clinical …, 2016 - Elsevier
Background & Aims It is not clear what serum levels of anti–tumor necrosis factor are
associated with reduced intestinal inflammation in patients with inflammatory bowel disease …

Endoscopic scoring indices for evaluation of disease activity in ulcerative colitis

NM Vashist, M Samaan, MH Mosli… - Cochrane Database …, 2018 - cochranelibrary.com
Background Endoscopic assessment of mucosal disease activity is routinely used to
determine eligibility and response to therapy in clinical trials of ulcerative colitis. The …

Curcumin in combination with mesalamine induces remission in patients with mild-to-moderate ulcerative colitis in a randomized controlled trial

A Lang, N Salomon, JCY Wu, U Kopylov… - Clinical …, 2015 - Elsevier
Background & Aims The phytochemical compound curcumin was reported to be effective in
maintaining remission in patients with ulcerative colitis (UC). We investigated curcumin's …